Literature DB >> 3281306

Can pulmonary vasodilators improve survival in cor pulmonale due to hypoxic chronic bronchitis and emphysema?

K F Whyte1, D C Flenley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3281306      PMCID： PMC461076          DOI： 10.1136/thx.43.1.1

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  69 in total

1.  Captopril and domiciliary oxygen in chronic airflow obstruction.

Authors:  C M Burke; M Harte; J Duncan; H M Connolly; J H Horgan; J Theodore; B Callaghan
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-27

2.  Augmentation of right ventricular performance in chronic obstructive pulmonary disease by terbutaline: a combined radionuclide and hemodynamic study.

Authors:  B N Brent; D Mahler; H J Berger; R A Matthay; L Pytlik; B L Zaret
Journal:  Am J Cardiol       Date:  1982-08       Impact factor: 2.778

3.  Predictors for early mortality in patients with long-term oxygen home therapy.

Authors:  R Keller; A Ragaz; P Borer
Journal:  Respiration       Date:  1985       Impact factor: 3.580

4.  Use of other physiological variables to predict pulmonary arterial pressure in patients with chronic respiratory disease. Multicentre study.

Authors:  J M Bishop; K W Cross
Journal:  Eur Heart J       Date:  1981-12       Impact factor: 29.983

5.  Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.

Authors:  T E Young; L J Lundquist; E Chesler; E K Weir
Journal:  Am J Cardiol       Date:  1983-01-01       Impact factor: 2.778

6.  Nifedipine dilates the pulmonary vasculature without producing symptomatic systemic hypotension in upright resting and exercising patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease.

Authors:  A Muramoto; J Caldwell; R K Albert; S Lakshminarayan; J Butler
Journal:  Am Rev Respir Dis       Date:  1985-11

7.  Early effects of intravenous terbutaline on cardiopulmonary function in chronic obstructive bronchitis and pulmonary hypertension.

Authors:  R M Jones; R A Stockley; J M Bishop
Journal:  Thorax       Date:  1982-10       Impact factor: 9.139

8.  Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease.

Authors:  E Weitzenblum; A Sautegeau; M Ehrhart; M Mammosser; A Pelletier
Journal:  Am Rev Respir Dis       Date:  1985-04

9.  Inhibition of hypoxic pulmonary vasoconstriction by nifedipine.

Authors:  T Kennedy; W Summer
Journal:  Am J Cardiol       Date:  1982-10       Impact factor: 2.778

10.  Improvement in cardiac performance by oral long-acting theophylline in chronic obstructive pulmonary disease.

Authors:  R A Matthay; H J Berger; R Davies; J Loke; A Gottschalk; B L Zaret
Journal:  Am Heart J       Date:  1982-11       Impact factor: 4.749
View more
  6 in total

Review 1.  Should patients have cardiac catheterization prior to long-term oxygen treatment?

Authors:  W MacNee
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Use of nitric oxide inhalation in chronic obstructive pulmonary disease.

Authors:  K Ashutosh; K Phadke; J F Jackson; D Steele
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Nasal oxygen in exacerbations of ventilatory failure: an underappreciated risk.

Authors:  R J Davies; J M Hopkin
Journal:  BMJ       Date:  1989-07-01

4.  Contractility of papillary muscle from rats exposed to 28 days of hypoxia, hypercapnia, and hypoxia with hypercapnia.

Authors:  S V Baudouin; N T Bateman
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

5.  Haemodynamic effects of atrial natriuretic peptide in hypoxic chronic obstructive pulmonary disease.

Authors:  T K Rogers; W Sheedy; J Waterhouse; P Howard; A H Morice
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

6.  Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension.

Authors:  Bita Hajian; Jan De Backer; Wim Vos; Cedric Van Holsbeke; Francisca Ferreira; Deborah A Quinn; Annemie Hufkens; Rita Claes; Wilfried De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.